关注第5版WHO造血与淋巴组织肿瘤分类变化  

Pay attention to the updates of 5th edition WHO classification of haematolymphoid tumours

作　　者：王哲 李小秋 Wang Zhe;Li Xiaoqiu(Department of Pathology,School of Basic Medicine,Fourth Military Medical University,Xi′an 710032,China;Department of Pathology,Fudan University Shanghai Cancer Center,Shanghai 200032,China)

机构地区：[1]空军军医大学病理学教研室,西安710032 [2]复旦大学附属肿瘤医院病理科,上海200032

出　　处：《中华病理学杂志》2024年第1期3-5,共3页Chinese Journal of Pathology

摘　　要：2022年,介绍第5版WHO造血与淋巴组织肿瘤分类变化的2篇综述发表于Leukemia杂志上,分类的全文版目前形成了国际癌症研究署网络β版,正式版本即将出版。本文简要提炼第5版WHO造血与淋巴组织肿瘤分类的一些重要进展和变化,从而指导淋巴造血组织肿瘤的精准分类和临床治疗。Two review articles summarizing the fifth edition of the World Health Organization(WHO)classification of haematolymphoid tumours were officially published on Leukemia journal in 2022.This article briefly summarizes some important advances and changes in the fifth edition of WHO classification of haematolymphoid tumours,and describes how to apply the classification dialectically and reasonably in the daily practice of pathologists,so as to accurately guide clinical treatments.

关 键 词：世界卫生组织 血液和淋巴系统疾病 病理学 临床 

分 类 号：R733.1[医药卫生—肿瘤]